Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Arrhythmia: full-pipeline trial registry
6 of 17 indexed Arrhythmia trials are currently recruiting.
Corpus placement: #1,004 of 28,707 conditions by registered trial count.
17 US clinical trials · 6 currently recruiting · #1,004 of 28,707 conditions by registered trial count
Arrhythmia: 17 US clinical trials tracked, 6 recruiting.
Arrhythmia is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Medtronic, running 3 of these trials.
Enrollment posture brief
Registry condition arrhythmia
OPEN 6 | RECR 35% | LATE 1 | EARLY 1 | RANK #1004 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Borderline Personality Disorder (35% recruiting · 17 trials)
Arrhythmia lists 6 open slots (35% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Arrhythmia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Arrhythmia is recruiting below its size-band peers.
6 of 17 indexed trials (35.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Arrhythmia research.
Medtronic accounts for 3 of 17 trials (17.6%). 15 distinct sponsors appear on at least one study for this condition label.
-
Typical Arrhythmia enrolment sits around 448 participants.
Median target enrolment is 448 among the 17 trials that report a genuine target (sentinel values excluded). 7 of those (41.2%) plan for fewer than 100 participants.
-
Arrhythmia splits between interventional and observational designs.
8 interventional and 9 observational studies make up this index (47.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
17 total, page 1 of 1
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Medtronic
NCT00271180
Genetics of Cardiovascular and Neuromuscular Disease
University of Chicago
NCT00138931
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Johns Hopkins University
NCT00733590
Aveir AR Coverage With Evidence Development (CED) Study
Abbott Medical Devices
NCT06100770
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
QuesGen Systems
NCT03604133
Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation
Malini Madhavan
NCT04685317
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
Cortex
NCT05883631
Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor
Belun Technology Company Limited
NCT06255613
Pediatric Adhesion and New Dermal Approach Study
iRhythm Technologies
NCT07118124
MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY
Medtronic
NCT01076374
CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse
Medtronic Cardiac Rhythm and Heart Failure
NCT00275769
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
Forest Laboratories
NCT00035490
Arrhythmias in Myotonic Muscular Dystrophy
Indiana University School of Medicine
NCT00622453
Model 4965 Post-Approval Study
Medtronic
NCT01076348
Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously
Wyeth is now a wholly owned subsidiary of Pfizer
NCT00510029
Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation
Steward St. Elizabeth's Medical Center of Boston
NCT01537237
Imaging With a Radio Tracer to Guide VT Ablations
University of Maryland, Baltimore
NCT01250912
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Arrhythmia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Arrhythmia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Arrhythmia page
17 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Arrhythmia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Medtronic sponsors the most Arrhythmia trials on record, review their full trial history before evaluating a specific study. See Medtronic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Arrhythmia condition card totals 17 registered trials; most-linked intervention GAP-134; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.